Cyclosporin A ameliorates mitochondrial ultrastructural injury in the ileum during acute endotoxemia

Critical Care Medicine

Volumn 30, Issue 12, 2002, Pages 2722-2728

  Crouser, Elliott D ^a   Julian, Mark W ^a   Joshi, Mandar S ^b   Bauer, John A ^b   Wewers, Mark D ^a   Hart, Judith M ^a   Pfeiffer, Douglas R ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b College of Pharmacy ^*  (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Electron microscopy; Feline; Permeability transition; Sepsis; Spectrophotometry

Indexed keywords

CYCLOSPORIN A; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON MICROSCOPY; ENDOTOXEMIA; ILEUM DISEASE; IMAGE ANALYSIS; INJURY SCALE; MALE; MEMBRANE PERMEABILITY; MITOCHONDRION; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESUSCITATION; SEPSIS; SPECTROPHOTOMETRY; TISSUE OXYGENATION; ULTRASTRUCTURE; ANALYSIS OF VARIANCE; ANIMAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; EVALUATION; INTRACELLULAR MEMBRANE; METABOLISM; PATHOPHYSIOLOGY; PERMEABILITY; RANDOMIZATION;

ANALYSIS OF VARIANCE; ANIMALS; CATS; CYCLOSPORINE; ENDOTOXEMIA; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR MEMBRANES; LIPOPOLYSACCHARIDES; MALE; MICROSCOPY, ELECTRON; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MULTIPLE ORGAN FAILURE; PERMEABILITY; RANDOM ALLOCATION; SPECTROPHOTOMETRY;

EID: 0036885023     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200212000-00017     Document Type: Article

References (41)

1. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ function. JAMA 1994; 271:226-233
2. Bersten A, Sibbald WJ: Circulatory disturbances in multiple systems organ failure. Crit Care Clin 1989; 5:233-269
3. Vandermeer TJ, Wang H, Fink MP: Endotoxin causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic model of septic shock. Crit Care Med 1995; 22:1217-1226
4. Revelly JP, Ayuse T, Brienza N, et al: Endotoxic shock alters distribution of blood flow in the intestinal wall. Crit Care Med 1996; 24:1345-1351
5. 2 alterations induced by endotoxin correlate with severity of mitochondrial injury. Am J Respir Crit Care Med 1999; 160:1347-1353
6. Crouser ED, Julian MW, Weinstein D, et al: Endotoxin-induced ileal mucosal injury and nitric oxide dysregulation are temporally dissociated. Am J Respir Crit Care Med 2000; 161:1705-1712
7. Crouser ED, Julian MW, Blaho DV, et al: Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002; 30:276-284
8. Boekstegers P, Weidenhofer S, Kapsner T, et al: Skeletal muscle partial pressure of oxygen in patients with sepsis. Circ Shock 1994; 33:17-25
9. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333: 1025-1032
10. Hayes MA, Timmins AC, Yau EHS, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
11. Joshi MS, Crouser ED, Julian MW, et al: Digital imaging analysis for the study of endotoxin-induced mitochondrial ultrastructure injury. Anal Cell Pathol 2000; 21:41-48
12. Kang YH, Falk MC, Bently TB, et al: Distribution and role of polysaccharide in the pathogenesis of acute renal tubule injury. Shock 1995; 4:441-449
13. Welty-Wolf KE, Simonson SG, Huang Y-C, et al: Ultrastructural changes in skeletal muscle mitochondria in Gram-negative sepsis. Shock 1996; 5:378-384
14. Hersch M, Gnidec AA, Bersten AD, et al: Histology and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 1990; 107:397-410
15. Friberg H, Ferrand-Drake M, Bengtsson F, et al: Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci 1998; 18:5151-5159
16. Li PA, Kristian T, He QP, et al: Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia. Exp Neurol 2000; 165:153-163
17. Zoratti M, Szabo I: The mitochondrial permeability transition. Biochim Biophys Acta 1995; 1241:139-176
18. Arora AS, Jones BJ, Patel TC, et al: Ceramide induces hepatocyte cell death through the disruption of mitochondrial function in the rat. Hepatology 1997; 25:958-963
19. 3 in vivo. J Appl Physiol 1977; 43:858-872
20. Allen JN, Herzyk DJ, Allen ED, et al: Human whole blood interleukin-1-[β] production: Kinetics, cell source, and comparison with TNF-[α]. J Lab Clin Med 1992; 119:538-546
21. Sokal RR, Rohlf FJ: Biometry. Second Edition. New York, Freeman, 1981
22. Marino MW, Dunn A, Grail D, et al: Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A 1997; 94:8093-8098
23. Broekemeier KM, Dempsey ME, Pfeiffer DR: Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 1989; 264: 7826-7830
24. Pfeiffer DR, Gudz TI, Novgorodov SA, et al: The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition. J Biol Chem 1995; 270:4923-4932
25. Fujii Y, Johnson ME, Gores GJ: Mitochondrial dysfunction during anoxia/reoxygenation injury of liver sinusoidal endothelial cells. Hepatology 1994; 20:177-185
26. Andersson J, Nagy S, Groth CG, et al: Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 1992; 75:136-142
27. Kantrow SP, Gierman JL, Jaligam VR, et al: Regulation of tumor necrosis factor toxicity by calcineurin. FEBS Lett 2000; 483:119-124
28. Hattori Y, Nakamishi N: Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobioterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. Cell Immunol 1995; 165:7-11
29. Brookes PS, Salinas EP, Darley-Usmar K, et al: Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 2000; 275:20474-20479
30. Ghafourifar P, Schenk U, Klein SD, et al: Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J Biol Chem 1999; 274:31185-31188
31. Conde M, Andrade J, Bedoya FJ, et al: Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology 1995; 84:476-481
32. Pastorino JG, Simbala G, Yamamoto K, et al: The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 1996; 271:29792-29798
33. Tafani M, Schneider TG, Pastorino JG, et al: Cytochrome c-dependent activation of caspase-3 by tumor necrosis factor requires induction of the mitochondrial permeability transition. Am J Pathol 2000; 156:2111-2121
34. Qian T, Nieminen AL, Herman B, et al: Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol 1997; 273:C1783-C1792
35. Portoles MT, Ainaga MJ, Pagani R: The induction of lipid peroxidation by E. coli lipopolysaccharide on rat hepatocytes as an important factor in the etiology of endotoxic liver damage. Biochim Biophys Acta 1993; 1158:287-292
36. 2 and cyclooxygenase 2. Biochem Biophys Res Commun 1996; 220:681-686
37. Garcia-Ruiz C, Colell A, Mari M, et al: Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 1997; 272:11369-11377
38. Piquet PF, Vesin C, Guo J, et al: TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur J Immunol 1998; 28:3499-3505
39. Neviere R, Fauvel H, Chopin C, et al: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 2001; 163:218-225
40. Wasaki S, Sakaida I, Uchida K, et al: Preventive effect of cyclosporin A on experimentally induced acute liver injury in rats. Liver 1997; 17:107-114
41. Mizoguchi Y, Kuboi H, Kodama C, et al: The protective effect of cyclosporin A on experimentally-induced acute hepatic failure. Gastroenterol Jpn 1987; 22:743-747